Cargando…
Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor
SIMPLE SUMMARY: Using a cell culture model of resistant breast cancer cells with the phenotype that is often responsible for the early relapse of triple-negative breast cancer, namely, the persistence of these cells in reversible quiescence under a variety of challenges, we found that reprogramming...
Autores principales: | Singh, Balraj, Sarli, Vanessa N., Lucci, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179491/ https://www.ncbi.nlm.nih.gov/pubmed/35681611 http://dx.doi.org/10.3390/cancers14112631 |
Ejemplares similares
-
Molecular architecture of the Jumonji C family histone demethylase KDM5B
por: Dorosz, Jerzy, et al.
Publicado: (2019) -
Systematic discovery of genetic modulation by Jumonji histone demethylases in Drosophila
por: Shalaby, Nevine A., et al.
Publicado: (2017) -
Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine
por: Singh, Balraj, et al.
Publicado: (2021) -
Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase
por: Sinha, Krishna M, et al.
Publicado: (2010) -
Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer
por: Singh, Balraj, et al.
Publicado: (2023)